Valid Soluções S.A (VLID3)
B3 Stock Exchange · Brazil · prices in BRL · close of 23 Oct 2026
Key indicators
| Last close | BRL 20.00 |
|---|---|
| 52-week range | 16.24 – 23.70 |
| Return, 1 month / 3 months | +15.4% / +13.3% |
| Return, 1 year / 3 years | +2.8% / +51.5% |
| Trend | Uptrend |
| RSI (14) | 65 |
| Volatility (1 year) | 35.2% |
| Worst drawdown (1 year) | -29.5% |
| Average daily value traded | 4.31M BRL |
| Dividend yield | 9.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Valid Soluções is a Brazilian company that provides security printing and identification services. It produces banknotes, passports, identity documents and payment cards for governments and financial institutions, and it supplies digital identification and mobile payment services. Its customers include public authorities, banks and businesses that need secure documents and payment products. The company is based in Brazil and serves clients in several countries.
Valid Soluções S.A trades under the code VLID3 on the B3 Stock Exchange in Brazil, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Valid Soluções S.A (VLID3) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 20.00 on 23 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 599 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 2.8% and over the last three months it rose 13.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 6.4% | ||
| From 52-week high | -15.3% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 13.3% | ||
| 6-month return | 3.3% | ||
| 12-month return, skipping the last month | -10.9% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.5% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 4.31M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 9.3% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +5.7% |
|---|---|
| 1 month | +15.4% |
| 3 months | +13.3% |
| 6 months | +3.3% |
| 1 year | +2.8% |
| 3 years | +51.5% |
| 5 years | +253.8% |
Signals
| 50-day / 200-day average | 17.73 / 18.80 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.69 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Nov 2026 | BRL 0.3765 |
| 12 Aug 2026 | BRL 0.1801 |
| 11 May 2026 | BRL 0.1802 |
| 28 Nov 2025 | BRL 1.5059 |
| 13 Mar 2025 | BRL 0.7874 |
| 20 Dec 2024 | BRL 0.1600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.